Treatment of basal cell carcinoma with curettage alone

Barlow, James O.; Zalla, Mark J.; Kyle, Amber; DiCaudo, David J.; Lim, Katherine K.; Yiannias, James A.

doi:10.1016/j.jaad.2006.01.041

Cited by 85 publications

(62 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…49,50 High-quality studies evaluating efficacy of ED&C are sparse in the literature. Recommendations for use of ED&C are thus primarily based on a long history of use and observation.…”

Section: Electrodesiccation and Curettagementioning

confidence: 99%

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

et al. 2015

View full text Add to dashboard Cite

Background: Basal cell carcinoma (BCC) is the most common malignancy. Growth of BCCs leads to local destruction of neighbouring healthy skin and underlying tissue and can result in significant functional and cosmetic morbidity. Objective: To provide guidance to Canadian health care practitioners regarding management of BCCs. Methods: Literature searches and development of graded recommendations were carried out as discussed in the accompanying Introduction. Results: Although BCCs rarely metastasize, they can be aggressive and disfiguring. This chapter describes the natural history and prognosis of BCCs. Risk stratification is based on clinical features, including the site and size of the tumour, its histologic subtype (nodular vs sclerosing), and its history of recurrence. Conclusions: Various options should be considered for BCC treatment, including cryosurgery, curettage, and topical or photodynamic approaches, as well as fixed-margin surgery and Mohs micrographic surgery. Stratification of recurrence risk for individual BCCs determines the most appropriate therapeutic course. RésuméContexte : Le carcinome basocellulaire (CBC) est le cancer le plus répandu. La croissance d'un CBC mène à la destruction locale de la peau saine environnante et des tissus sous-jacents et peut causer une morbidité fonctionnelle et cosmétique importante. Objectif : Fournir des conseils aux professionnels canadiens de la santé au sujet de la gestion des CBC. Méthode : Nous avons procédé à une étude documentaire et à l'élaboration de catégories de recommandations, comme on peut le lire dans l'introduction connexe. Résultats : Le CBC forme rarement des métastases, mais il peut être agressif et défigurant. Ce chapitre décrit l'évolution et le pronostic du CBC. La stratification du risque est fondée sur les caractéristiques cliniques, y compris l'emplacement et la taille de la tumeur, et son sous-type histologique (nodulaire ou sclérosant), et sur les antécédents de récurrence. Conclusion : Diverses options devraient être envisagées dans le traitement du CBC, y compris la cryochirurgie, le curetage et les approches topiques ou photodynamiques, ainsi que la chirurgie à marge déterminée et la chirurgie micrographique de Mohs. La stratification du risque de récurrence de chaque CBC individuel détermine le traitement thérapeutique le plus approprié.

show abstract

“…49,50 High-quality studies evaluating efficacy of ED&C are sparse in the literature. Recommendations for use of ED&C are thus primarily based on a long history of use and observation.…”

Section: Electrodesiccation and Curettagementioning

confidence: 99%

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

et al. 2015

View full text Add to dashboard Cite

show abstract

“…55 For appropriately selected tumors, curettage alone has been shown to have a cure rate equal to that of C&E, with better healing. 94 Curettage and electrodesiccation should not be used for tumors present on terminal hair-bearing skin because of the risk of tumor extension along follicular structures. If the subcutaneous layer reached during the curettage or the biopsy result obtained from the curettage reveals a high-risk BCC subtype, SSE or Mohs surgery is recommended.…”

Section: Curettage and Electrodesiccationmentioning

confidence: 99%

Consensus for Nonmelanoma Skin Cancer Treatment

Kauvar

Cronin

Roenigk

et al. 2015

Dermatologic Surgery

141

View full text Add to dashboard Cite

show abstract

“…16 In addition, it has been reported that 75% of tumors contained areas demonstrating more than one histologic type. 17 Our study showed a concordance rate of only 62% between subtype identified on biopsy specimens and the subsequent excisions, with 44% of those biopsy specimens containing a secondary subtype (eg, nodular type with a secondary micronodular component).…”

Section: Discussionmentioning

confidence: 51%